Table 2 Regimens used for the first chemotherapy
From: Chemoresponse after non-curative gastrectomy for M1 gastric cancer
Regimen | Total ( n = 101) | CTx ( n = 76) | NCG + CTx ( n = 25) |
|---|---|---|---|
Paclitaxel/cisplatin/TS-1 | 27 | 24 | 3 |
Paclitaxel/cisplatin | 21 | 21 | |
Capecitabine/cisplatin | 9 | 2 | 7 |
FOLFOX (folinic acid/5-FU/oxaliplatin) | 7 | 2 | 5 |
Paclitaxel/TS-1 | 6 | 5 | 1 |
Irinotecan/cisplatin | 5 | 4 | 1 |
Docetaxel/oxaliplatin | 5 | 4 | 1 |
5-FU/cisplatin | 4 | 3 | 1 |
Heptaplatin/5-FU | 4 | 4 | |
FOLFIRI (folinic acid/5-FU/irinotecan) | 3 | 3 | |
Docetaxel/5-FU/cisplatin | 2 | 2 | |
TS-1 | 2 | 2 | |
FOLFOX/cetuximab | 1 | 1 | |
Capecitabine/lapatinib/eloxatin | 1 | 1 | |
MFC (MMC/5-FU/cytarabine) | 1 | 1 | |
Docetaxel/cisplatin | 1 | 1 | |
TS-1/cisplatin | 1 | 1 | |
Capecitabine/lapatinib | 1 | 1 |